subject: CHEBI:94518


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: cephalocele

tested_intervention: unsure


subject: CHEBI:94518

object_name: Encephalocele


subject: CHEBI:5775

subject_name: Hydralazine

object_name: cervical cancer


subject: CHEBI:5775

object_name: cervical carcinoma


subject: UNII:Q400352CM2


subject: UNII:Q400352CM2


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: UMLS:C5575704

subject_name: Gene Therapy [APC]

object_name: cervical squamous intraepithelial neoplasia

tested_intervention: yes


subject: UMLS:C5575704

object_name: cervical intraepithelial neoplasia


subject: UMLS:C5575704

object_name: dysplasia of cervix


subject: UMLS:C5575704

object_name: cervical polyp


subject: UMLS:C5575704

object_name: oropharynx cancer


subject: UMLS:C5575704

object_name: neoplasm of oropharynx


subject: UMLS:C0306945

subject_name: Neo-Synalar Cream

object_name: Allergy


subject: UMLS:C0306945

object_name: History of allergies


subject: RXCUI:1191359

subject_name: fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream


subject: RXCUI:1191359


subject: UMLS:C2981846

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:63453


subject: UMLS:C3502775


subject: CHEBI:132986

subject_name: Sapitinib


subject: MESH:C548875


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:231369

subject_name: Savolitinib


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: CHEBI:135515

subject_name: Bendamustine

object_name: CCND1 Positive


subject: CHEBI:135515

object_name: t(11;14) Positive


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Duchenne muscular dystrophy


subject: UMLS:C0075665

subject_name: Sustanon


subject: CHEBI:17347

subject_name: Testosterone


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UNII:7SE5582Q2P

subject_name: Vosoritide

object_name: hypochondroplasia


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: Post-Operative Pain


subject: CHEBI:3745

subject_name: clindamycin

object_name: Neck Carcinoma


subject: CHEBI:3745

object_name: head and neck neoplasm


subject: CHEBI:3745

object_name: head and neck cancer


subject: CHEBI:3745

object_name: colorectal cancer


subject: CHEBI:3745

object_name: colorectal carcinoma


subject: CHEBI:3745

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:35341

subject_name: steroid


subject: CHEBI:35341


subject: CHEBI:35341


subject: CHEBI:35341


subject: CHEBI:35341


subject: CHEBI:35341


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: UMLS:C5782153


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: insomnia


subject: CHEBI:68558

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:68558

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3244644

subject_name: Nucynta ER

object_name: Chronic low back pain


subject: UMLS:C3244644

object_name: chronic back pain


subject: PUBCHEM.COMPOUND:54671203

object_name: Reperfusion Injury


subject: UMLS:C1611967

object_name: Blood Clot


subject: UMLS:C1611967

object_name: thrombosis


subject: UMLS:C1611967

object_name: Thrombosis of blood vessel


subject: UMLS:C1611967

object_name: Thromboembolism


subject: UMLS:C1611967

object_name: venous thromboembolism


subject: UMLS:C1611967

object_name: thrombophilia due to thrombin defect


subject: UMLS:C1611967

object_name: Venous thrombosis after immobility


subject: UMLS:C2348691

subject_name: Fluorine F-18 HX4

object_name: rectal carcinoma


subject: UMLS:C2348691

object_name: rectal cancer


subject: UMLS:C2348691

object_name: Childhood Rectal Carcinoma


subject: UMLS:C2348691

object_name: carcinoma of esophagus


subject: UMLS:C2348691

object_name: esophageal cancer


subject: UMLS:C2348691

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C2348691

object_name: neoplasm of esophagus


subject: UMLS:C3541972

subject_name: Carbohydrate nutrients

object_name: Stomach cancer


subject: UMLS:C3541972

object_name: gastric cancer


subject: UMLS:C3541972

object_name: malnutrition


subject: CHEBI:16646

subject_name: carbohydrate


subject: CHEBI:16646


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3540032


subject: UMLS:C3540032


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: UMLS:C5707733

subject_name: Copper Cu 64 SAR-Bombesin

object_name: Non-metastatic prostate cancer


subject: DRUGBANK:DB05579

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: DRUGBANK:DB05579

object_name: amyotrophic lateral sclerosis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767

object_name: Metastatic cholangiocarcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV

object_name: Cholangiocarcinoma non-resectable


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:23965

subject_name: estradiol

object_name: Menstrual cycle and uterine bleeding disorders


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: UMLS:C4760178

subject_name: Neuromuscular blockade drugs

object_name: Neuromuscular inhibition


subject: UMLS:C4760178

object_name: Neuromuscular block, function


subject: UMLS:C4760178

object_name: Extracorporeal membrane oxygenation complication


subject: UMLS:C4760178

object_name: respiratory failure


subject: UMLS:C4760178

object_name: bronchopulmonary dysplasia


subject: UMLS:C4760178

object_name: Respiratory insufficiency


subject: UMLS:C5777101

object_name: tumor of salivary gland


subject: UMLS:C5777101

object_name: salivary gland cancer


subject: UMLS:C5777101

object_name: urothelial carcinoma


subject: UMLS:C5777101

object_name: transitional cell carcinoma


subject: UMLS:C5777101

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5777101

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5777101

object_name: sarcoma


subject: UMLS:C5777101

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5777101

object_name: soft tissue sarcoma


subject: UMLS:C5777101

object_name: ovarian cancer


subject: UMLS:C5777101

object_name: ovarian carcinoma


subject: UMLS:C5777101

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5777101

object_name: Childhood Breast Carcinoma


subject: UMLS:C5777101

object_name: breast carcinoma


subject: UMLS:C5777101

object_name: breast cancer


subject: UNII:P848LCX62B

subject_name: Rostafuroxin

object_name: essential hypertension


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: schizophrenia


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Recurrent acute tonsillitis


subject: CHEBI:7025

subject_name: Mupirocin

object_name: outcomes general quality of life


subject: CHEBI:7025

object_name: Perceived quality of life


subject: CHEBI:7025

object_name: Good quality of life


subject: CHEBI:7025

object_name: nasopharyngeal carcinoma


subject: CHEBI:7025

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:7025

object_name: Bacterial Colonization


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Epstein-Barr virus-associated gastric carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: MESH:C079198

subject_name: S 1 (combination)


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C0723176

subject_name: SFC (Brand Name)

object_name: asthma


subject: UNII:KXQ762CQTH

object_name: Advanced cancer


subject: UNII:J6U9WP10T7


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Esophageal squamous cell carcinoma thoracic stage IV


subject: GTOPDB:12990

object_name: Esophageal squamous cell carcinoma thoracic stage II


subject: GTOPDB:12990

object_name: Esophageal squamous cell carcinoma thoracic stage III


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: CHEBI:34650

subject_name: COLISTIMETHATE

object_name: Acinetobacter infectious disease


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: diabetes mellitus


subject: CHEBI:38848

subject_name: perflunafene


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: CHEBI:119915

subject_name: Fentanyl

object_name: congenital alveolar dysplasia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: B-Cell Malignant Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Childhood Breast Carcinoma


subject: UMLS:C5848866

object_name: breast carcinoma


subject: UMLS:C5848866

object_name: breast cancer


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: intracerebral hemorrhage


subject: CHEBI:149601

subject_name: Bempedoic acid


subject: UMLS:C5445109

subject_name: PCSK9 Inhibitors


subject: UMLS:C1449704

subject_name: Fibrates


subject: UMLS:C3540783

subject_name: Fibrates, lipid modifying drugs, plain


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: HIV infection


subject: UMLS:C3641122


subject: UMLS:C5854480

subject_name: Anti-CD44v9 Antibody-drug Conjugate AMT-116

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:231614

subject_name: Nivolumab

object_name: T-Cell Lymphoma


subject: CHEBI:231614

object_name: Aggressive Non-Hodgkin Lymphoma


subject: CHEBI:231614

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:62880

subject_name: Veliparib

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:62880


subject: CHEBI:62880

object_name: Mantle cell lymphoma refractory


subject: CHEBI:62880


subject: CHEBI:62880


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Recurrent Lung Non-Squamous Non-Small Cell Carcinoma


subject: UNII:KXG2PJ551I

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Advanced Lung Non-Squamous Non-Small Cell Carcinoma


subject: UNII:KXG2PJ551I

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: CHEBI:143565

subject_name: Lisofylline

object_name: type 1 diabetes mellitus 1


subject: CHEBI:143565

object_name: type 1 diabetes mellitus


subject: UMLS:C1704263

subject_name: green tea extract

object_name: Inflammation


subject: UMLS:C1704263

object_name: Endotoxemia


subject: UMLS:C1704263

object_name: Dysbiosis


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: DRUGBANK:DB14307


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: ductal breast carcinoma in situ


subject: CHEBI:73604

object_name: invasive ductal breast carcinoma


subject: CHEBI:34922

subject_name: picloram

object_name: hepatitis C


subject: UNII:9GE48QZN6X


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Estrogen Receptor Positive


subject: CHEBI:230905

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:230905

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:230905

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Cross Infection


subject: CHEBI:193615

object_name: metastatic colorectal cancer


subject: CHEBI:60761

subject_name: Floxuridine


subject: UMLS:C0021745

subject_name: interferon type II

object_name: Genital warts


subject: UMLS:C0021745

object_name: human papilloma virus infection


subject: UMLS:C3539881

subject_name: gamma-interferon


subject: UMLS:C3539881


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: bipolar depression


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: urinary tract infection


subject: DRUGBANK:DB19249

object_name: Recurrent urinary tract infections


subject: DRUGBANK:DB19249

object_name: Recurrent tumor


subject: DRUGBANK:DB19249

object_name: Infection


subject: DRUGBANK:DB19249

object_name: Infection of musculoskeletal system


subject: DRUGBANK:DB19249

object_name: primary interstitial lung disease specific to childhood


subject: DRUGBANK:DB19249

object_name: interstitial lung disease specific to childhood


subject: DRUGBANK:DB19249

object_name: infectious disease


subject: DRUGBANK:DB19249

object_name: urinary system disorder


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements


subject: CHEBI:91397

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:91397

object_name: Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: CHEBI:91397

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:91397

object_name: Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: CHEBI:91397

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: CHEBI:91397

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:O43472U9X8

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:O43472U9X8

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:O43472U9X8

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:O43472U9X8


subject: CHEBI:8382

subject_name: Prednisone

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:145374

subject_name: Enasidenib

object_name: Childhood Solid Neoplasm


subject: CHEBI:145374

object_name: Adult Solid Neoplasm


subject: CHEBI:145374

object_name: Solid Neoplasm


subject: CHEBI:145374

object_name: glioma


subject: CHEBI:145374

object_name: malignant glioma


subject: CHEBI:145374

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:145374

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:145374

object_name: bone chondrosarcoma


subject: CHEBI:145374

object_name: chondrosarcoma


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Cytopenia


subject: CHEBI:38290

object_name: Chronic Myelomonocytic Leukemia-1


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:50730

subject_name: Montelukast

object_name: Chronic uremia


subject: UNII:3JL137394Y

object_name: pseudotumor cerebri


subject: GTOPDB:5962

subject_name: dovitinib

object_name: salivary gland cancer


subject: GTOPDB:5962

object_name: corpus callosum, agenesis of


subject: GTOPDB:5962

object_name: Congenital scar


subject: CHEBI:28741

subject_name: Sodium fluoride

object_name: Dental Caries, CTCAE


subject: UMLS:C1171560

subject_name: Natrium fluoratum, sodium fluoride, Homeopathic preparation

object_name: dental caries


subject: UMLS:C1171560


subject: GTOPDB:10492

subject_name: envafolimab

object_name: Stomach cancer


subject: GTOPDB:10492

object_name: gastric cancer


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Chronic idiopathic constipation


subject: UNII:UC95NQ339C

object_name: Functional constipation


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Advanced Biliary Tract Carcinoma


subject: GTOPDB:9758

object_name: Advanced Bile Duct Carcinoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:5S371K6132


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:32188

subject_name: Tegafur


subject: CHEBI:32188


subject: UMLS:C0678113

subject_name: Actilyse

object_name: pulmonary embolism


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: Primary malignant neoplasm


subject: UNII:9AG41L3AOQ

object_name: cancer


subject: UNII:9AG41L3AOQ

object_name: childhood malignant neoplasm


subject: UNII:9AG41L3AOQ

object_name: Malignant obstetric neoplasm


subject: UMLS:C0003402

subject_name: Antioxidants

object_name: type 2 diabetes mellitus


subject: MESH:D014131

subject_name: Trace Elements


subject: UMLS:C0282575

subject_name: Micronutrients


subject: UNII:350H6PBQ5Q

object_name: Advanced cancer


subject: UMLS:C3661065


subject: CHEBI:77262

subject_name: (R)-omeprazole


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:36791

subject_name: Escitalopram

object_name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:125535

subject_name: Esreboxetine


subject: CHEBI:135342

subject_name: Reboxetine


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:9943

subject_name: Venlafaxine


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: skin sarcoma


subject: DRUGBANK:DB17293

object_name: Basal Cell Cancer


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UMLS:C5417882

subject_name: Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318

object_name: extranodal nasal NK/T cell lymphoma


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist

object_name: ovarian hyperstimulation syndrome


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: CHEBI:59224

subject_name: Cetrorelix


subject: CHEBI:6121

subject_name: Ketamine

object_name: pharyngitis


subject: CHEBI:6121

object_name: Pharyngalgia


subject: CHEBI:6121

object_name: Sore Throat, CTCAE


subject: UMLS:C4733481

object_name: neoplasm


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Myelodysplasia


subject: CHEBI:15927

object_name: acute lymphoblastic leukemia


subject: CHEBI:15927

object_name: lymphoid leukemia


subject: CHEBI:15927

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:15927

object_name: aplastic anemia


subject: CHEBI:15927

object_name: idiopathic aplastic anemia


subject: CHEBI:15927

object_name: myeloid leukemia


subject: CHEBI:16118

subject_name: Berberine

object_name: Prediabetes


subject: CHEBI:16118

object_name: Android obesity


subject: CHEBI:16118

object_name: hypertension


subject: CHEBI:16118

object_name: Hypertension, CTCAE


subject: CHEBI:67271

object_name: HER2 positive breast carcinoma


subject: CHEBI:67271

object_name: male breast carcinoma


subject: CHEBI:67271

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:67271

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:67271

object_name: stage IV esophageal cancer


subject: CHEBI:67271

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:67271

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:67271

object_name: stage IIIC esophageal cancer


subject: CHEBI:67271

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:49603

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:49603

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C4722671

subject_name: Myelo 001

object_name: Chemotherapy induced neutropenia


subject: UMLS:C4722671

object_name: Childhood Breast Carcinoma


subject: UMLS:C4722671

object_name: breast carcinoma


subject: UMLS:C4722671

object_name: breast cancer


subject: UMLS:C4722671

object_name: myelosuppression


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:63605

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:63605

object_name: gallbladder cancer


subject: CHEBI:63605

object_name: Localized Gallbladder Carcinoma


subject: CHEBI:63605

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:63605

object_name: cholangiocarcinoma of the gallbladder


subject: CHEBI:63605

object_name: advanced adult primary liver cancer


subject: CHEBI:63605

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:63605

object_name: Localized Resectable Adult Liver Carcinoma


subject: CHEBI:63605

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:63605

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: CHEBI:63605

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:63605

object_name: Localized Extrahepatic Bile Duct Carcinoma


subject: CHEBI:63605

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:63605

object_name: cholangiocarcinoma


subject: CHEBI:15377

subject_name: Water

object_name: schizoaffective disorder


subject: CHEBI:15377

object_name: schizophrenia 18


subject: CHEBI:15377

object_name: schizophrenia


subject: CHEBI:15377

object_name: Weight Gain


subject: CHEBI:15377

object_name: Weight Gain, CTCAE


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: CHEBI:32016

object_name: acute respiratory distress syndrome


subject: CHEBI:32016

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: CHEBI:32016


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: chronic obstructive pulmonary disease


subject: UMLS:C2718754

subject_name: Ilaris


subject: UNII:K8V5DLS63R

object_name: kidney failure


subject: UMLS:C3852921

subject_name: saroglitazar magnesium


subject: CHEBI:7553

subject_name: Niclosamide

object_name: adult acute myeloid leukemia


subject: CHEBI:7553

object_name: childhood acute myeloid leukemia


subject: CHEBI:7553

object_name: acute myeloid leukemia


subject: CHEBI:60802

subject_name: ropivacaine

object_name: temporomandibular joint disorder


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: melancholia


subject: CHEBI:32139

object_name: Local anesthetic agent poisoning


subject: CHEBI:32139

object_name: Poisoning by, adverse effect of and underdosing of local anesthetics


subject: CHEBI:32139

object_name: Local anaesthetics causing adverse effects in therapeutic use


subject: CHEBI:32139

object_name: Exposed to vibration


subject: CHEBI:41060

subject_name: IBANDRONATE

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:41060

object_name: Embolism, Tumor


subject: CHEBI:41060

object_name: Neoplasm Metastasis


subject: CHEBI:41060

object_name: humoral hypercalcemia of malignancy


subject: UNII:UMD7G2653W

subject_name: Ibandronate


subject: UNII:UMD7G2653W


subject: UNII:UMD7G2653W


subject: UNII:UMD7G2653W


subject: UMLS:C0392938

subject_name: zoledronate


subject: UMLS:C0392938


subject: CHEBI:5893

subject_name: Indapamide


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Ehlers-Danlos syndrome


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: immunodeficiency disease


subject: CHEBI:8665

object_name: HIV-1 infection


subject: CHEBI:8665


subject: CHEBI:177769

subject_name: Sovaprevir

object_name: chronic hepatitis C virus infection


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: osteoarthritis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Adenocarcinoma of the prostate stage IV


subject: UNII:DPT0O3T46P

object_name: PSA Progression


subject: GTOPDB:8313

subject_name: talazoparib

object_name: hematopoietic and lymphoid system neoplasm


subject: GTOPDB:8313

object_name: Malignant Solid Neoplasm


subject: GTOPDB:8313

object_name: adrenal gland pheochromocytoma


subject: GTOPDB:8313

object_name: paraganglioma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C4725071

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: colon carcinoma


subject: UNII:997WVV895X

object_name: colorectal cancer


subject: UNII:997WVV895X

object_name: colon cancer


subject: UNII:DPT0O3T46P

object_name: Lymphoma, Extranodal NK-T-Cell


subject: CHEBI:177413

subject_name: Plinabulin

object_name: cancer


subject: CHEBI:177413

object_name: neoplasm


subject: UMLS:C1741609


subject: UMLS:C1741609


subject: UMLS:C5417787

object_name: melanoma


subject: UMLS:C4722731

subject_name: INXN 2001


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: trabecular adenocarcinoma


subject: UNII:2Y3T5IF01Z

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: CHEMBL.COMPOUND:CHEMBL4594559

subject_name: TUPARSTOBART


subject: CHEMBL.COMPOUND:CHEMBL4594559


subject: UNII:KAC8QY6TMN

subject_name: VERZISTOBART


subject: UNII:KAC8QY6TMN


subject: CHEBI:93775

subject_name: Amethopterin

object_name: osteoarthritis, knee


subject: CHEBI:93775

object_name: Knee pain


subject: CHEBI:93775

object_name: hydrarthrosis


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: UNII:51M3FB9B9E

object_name: diabetic macular edema


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: glioblastoma


subject: GTOPDB:9592

object_name: Childhood Glioblastoma


subject: GTOPDB:9592

object_name: adult glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:132082

subject_name: Entinostat

object_name: Myelodysplasia


subject: CHEBI:132082

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:132082

object_name: childhood myelodysplastic syndrome


subject: CHEBI:132082

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:C82R061MZ5

object_name: type 2 diabetes mellitus


subject: UNII:8JYO8VTR11


subject: MESH:C546417

subject_name: Neuroaid

object_name: stroke disorder


subject: MESH:C546417

object_name: cerebrovascular disorder


subject: MESH:C546417

object_name: Stroke (heart beat)


subject: MESH:C546417

object_name: Stroke, CTCAE


subject: MESH:C546417

object_name: cerebral infarction


subject: UMLS:C1145198

subject_name: INJECTION, INSULIN, PER 5 UNITS

object_name: type 1 diabetes mellitus 1


subject: UMLS:C1145198

object_name: type 1 diabetes mellitus


subject: MESH:D001786

subject_name: Blood Glucose


subject: MESH:D001786


subject: UNII:60ES45KTMK

subject_name: Pilaralisib

object_name: Solid Neoplasm


subject: UMLS:C3657458


subject: CHEBI:71957


subject: UMLS:C5417930


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Ischemic stroke


subject: CHEBI:9241

object_name: intracerebral hemorrhage


subject: CHEBI:124959

subject_name: Tilarginine

object_name: Carcinoma breast stage IV


subject: CHEBI:124959

object_name: metaplastic breast carcinoma


subject: CHEBI:124959

object_name: Her2-receptor negative breast cancer


subject: CHEBI:124959

object_name: triple-negative breast carcinoma


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: CHEBI:75998

subject_name: Trametinib

object_name: Recurrent Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEBI:75998

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: PR:000023609

subject_name: propionate--CoA ligase

object_name: ischemia


subject: PR:000023609

object_name: peripheral vascular disease


subject: PR:000023609

object_name: diabetic foot


subject: PR:000023609

object_name: Leg Ulcer


subject: PR:000023609

object_name: Gangrene


subject: UNII:74T7185BMM

subject_name: Inebilizumab

object_name: Myasthenia Gravis, Generalized


subject: UMLS:C2981806


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: opiate dependence


subject: CHEBI:146178

object_name: substance-related disorder


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEMBL.COMPOUND:CHEMBL2109562

subject_name: CAL

object_name: Chronic small plaque psoriasis


subject: PR:000008147

subject_name: Golgi-associated PDZ and coiled-coil motif-containing protein


subject: UMLS:C1135160

subject_name: monoclonal antibody CAL


subject: PR:000007357

subject_name: filamin-binding LIM protein 1


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: hepatic encephalopathy


subject: UMLS:C0013227

object_name: hepatitis C


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C2346810

object_name: Advanced Angiosarcoma


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate

object_name: metabolic bone disorder


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: atopic eczema


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Fibrillary astrocytoma of brain


subject: UNII:2S9ZZM9Q9V

object_name: oligoastrocytoma


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: eosinophilic granulomatosis with polyangiitis


subject: CHEBI:134738

subject_name: Laquinimod

object_name: eye disorder


subject: CHEBI:71219

subject_name: Pazopanib

object_name: prostate carcinoma


subject: CHEBI:71219

object_name: prostate cancer


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: abdominal obesity-metabolic syndrome


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: CHEBI:151315

subject_name: Heparin


subject: KEGG.COMPOUND:C00374


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: Richter syndrome


subject: UMLS:C4725069

subject_name: glofitamab


subject: CHEBI:39867

subject_name: Valproic acid

object_name: childhood myelodysplastic syndrome


subject: CHEBI:39867

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0359156

subject_name: Thymoglobulin

object_name: euthyroid Graves orbitopathy


subject: UMLS:C0359156

object_name: endocrine exophthalmos


subject: UNII:2LHZ9ZC3YO

subject_name: Tolinapant

object_name: cervical cancer


subject: UNII:2LHZ9ZC3YO

object_name: cervical carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: triple-negative breast carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:2LHZ9ZC3YO

object_name: Advanced cancer


subject: CHEBI:232048

object_name: Acne inversa


subject: MESH:C030259

subject_name: Broncho-Vaxom

object_name: Wheezing


subject: MESH:C030259

object_name: Wheezing, CTCAE


subject: MESH:C030259

object_name: asthma


subject: DRUGBANK:DB16533


subject: DRUGBANK:DB16533


subject: DRUGBANK:DB16533


subject: UNII:FU77B4U5Z0

object_name: Pemphigoid


subject: UMLS:C5784711

subject_name: Anti-ALPP/ALPPL2/MMAE ADC SGN-ALPV

object_name: Gastroesophageal Junction Carcinoma


subject: UMLS:C5784711

object_name: non-small cell lung carcinoma


subject: UMLS:C5784711

object_name: cervical polyp


subject: UMLS:C5784711

object_name: neoplasm of testis


subject: UMLS:C5784711

object_name: testicular cancer


subject: UMLS:C5784711

object_name: endometrium neoplasm


subject: UMLS:C5784711

object_name: gastric neoplasm


subject: UMLS:C5784711

object_name: ovarian cancer


subject: UMLS:C5784711

object_name: ovarian neoplasm


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:M89N0Q7EQR

object_name: stage IV pancreatic cancer


subject: UNII:M89N0Q7EQR

object_name: Pancreatic carcinoma stage III


subject: UNII:M89N0Q7EQR

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:M89N0Q7EQR

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:M89N0Q7EQR

object_name: Pancreatic carcinoma recurrent


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:61080

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:61080

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:61080

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:61080

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:61080


subject: CHEBI:61080

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:61080


subject: CHEBI:61080

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:61080

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage IV Lung Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage III Lung Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:61080

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:61080

object_name: Stage IV Colorectal Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage III Colorectal Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage IIIA Colorectal Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage IIIB Colorectal Cancer AJCC v7


subject: CHEBI:61080

object_name: Stage IIIC Colorectal Cancer AJCC v7


subject: CHEBI:61080

object_name: Unresectable Solid Neoplasm


subject: CHEBI:61080

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:61080

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:61080

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:61080

object_name: Renal cell carcinoma recurrent


subject: CHEBI:61080

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:61080

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: CHEBI:61080

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: CHEBI:61080

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: CHEBI:61080

object_name: Stage III Soft Tissue Sarcoma AJCC v7


subject: CHEBI:61080

object_name: Stage IV Soft Tissue Sarcoma AJCC v7


subject: CHEBI:61080

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: CHEBI:61080

object_name: Prostate cancer recurrent


subject: CHEBI:61080

object_name: Colorectal cancer recurrent


subject: CHEBI:61080

object_name: Bladder cancer recurrent


subject: CHEBI:61080

object_name: Breast cancer recurrent


subject: CHEBI:61080

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:61080

object_name: neuroendocrine neoplasm


subject: CHEBI:61080

object_name: Melanoma recurrent


subject: CHEBI:61080

object_name: glioma


subject: CHEBI:61080

object_name: malignant glioma


subject: UMLS:C0963679

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C0963679

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C0963679

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C0963679

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C0963679

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0963679

object_name: Stage III Prostate Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0963679

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C0963679

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage IV Lung Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage III Lung Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C0963679

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C0963679

object_name: Stage IV Colorectal Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage III Colorectal Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage IIIA Colorectal Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage IIIB Colorectal Cancer AJCC v7


subject: UMLS:C0963679

object_name: Stage IIIC Colorectal Cancer AJCC v7


subject: UMLS:C0963679

object_name: Unresectable Solid Neoplasm


subject: UMLS:C0963679

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0963679

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C0963679

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C0963679

object_name: Renal cell carcinoma recurrent


subject: UMLS:C0963679

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C0963679

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: UMLS:C0963679

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: UMLS:C0963679

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: UMLS:C0963679

object_name: Stage III Soft Tissue Sarcoma AJCC v7


subject: UMLS:C0963679

object_name: Stage IV Soft Tissue Sarcoma AJCC v7


subject: UMLS:C0963679

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: UMLS:C0963679

object_name: Prostate cancer recurrent


subject: UMLS:C0963679

object_name: Colorectal cancer recurrent


subject: UMLS:C0963679

object_name: Bladder cancer recurrent


subject: UMLS:C0963679

object_name: Breast cancer recurrent


subject: UMLS:C0963679

object_name: Recurrent Unspecified Lung Carcinoma


subject: UMLS:C0963679

object_name: neuroendocrine neoplasm


subject: UMLS:C0963679

object_name: Melanoma recurrent


subject: UMLS:C0963679

object_name: glioma


subject: UMLS:C0963679

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:2269

object_name: Malnutrition in pregnancy


subject: PUBCHEM.COMPOUND:2269

object_name: malnutrition


subject: PUBCHEM.COMPOUND:2269

object_name: hereditary endocrine growth disease


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: PUBCHEM.COMPOUND:157010259


subject: PUBCHEM.COMPOUND:157010259

object_name: Pregnant


subject: PUBCHEM.COMPOUND:157010259


subject: PUBCHEM.COMPOUND:157010259


subject: CHEBI:16199

subject_name: Urea

object_name: tinea unguium


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:499361

subject_name: Aprepitant

object_name: digestive system neoplasm


subject: CHEBI:499361

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C5237063

subject_name: Multi-epitope HER2 Peptide Vaccine H2NVAC

object_name: ductal breast carcinoma in situ


subject: DRUGBANK:DB18652

object_name: Reperfusion Injury


subject: DRUGBANK:DB18652

object_name: Disorder of transplanted kidney


subject: UMLS:C5226476

object_name: Erosive esophagitis


subject: UMLS:C5402536

subject_name: Breztri Aerosphere

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C5402536

object_name: COPD, severe early onset


subject: UMLS:C5402536

object_name: chronic obstructive pulmonary disease


subject: CHEBI:9150

subject_name: Simvastatin

object_name: sickle cell disease


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: Psoriasis of scalp


subject: UNII:90ZX3Q3FR7

object_name: Psoriasis genital


subject: UMLS:C4078397


subject: UMLS:C4078397


subject: CHEBI:48538

subject_name: Apomorphine

object_name: progressive supranuclear palsy


subject: CHEBI:48538

object_name: corticobasal degeneration disorder


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: Childhood Solid Neoplasm


subject: CHEBI:146178

object_name: Adult Solid Neoplasm


subject: CHEBI:146178

object_name: Solid Neoplasm


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:48923

subject_name: erythromycin

object_name: blepharitis


subject: CHEBI:42355

subject_name: Erythromycin


subject: UMLS:C0876064

subject_name: Lantus

object_name: maturity-onset diabetes of the young type 1


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: Plasma cell myeloma recurrent


subject: UMLS:C5226733

object_name: chronic idiopathic urticaria


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: TRAUMA/INJURY PROBLEM


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C4048712

subject_name: factor IX complex


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Abnormality of temperature regulation


subject: CHEBI:84500

subject_name: varenicline

object_name: type 2 diabetes mellitus


subject: CHEBI:84500

object_name: Diabetes


subject: CHEBI:84500

object_name: diabetes mellitus


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: Malignant neoplasm of female breast


subject: UMLS:C5669600

object_name: female breast carcinoma


subject: GTOPDB:13497

subject_name: axatilimab

object_name: Hodgkin Disease


subject: GTOPDB:13497

object_name: Adult Hodgkin Lymphoma


subject: GTOPDB:13497

object_name: Childhood Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4594608

subject_name: AXATILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Radiation Sickness


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: intracerebral hemorrhage


subject: CHEBI:6801

subject_name: Metformin

object_name: breast carcinoma in situ


subject: CHEBI:6801

object_name: Carcinoma breast stage I


subject: CHEBI:6801

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:6801

object_name: Breast carcinoma NOS stage III


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: UNII:71M78END5S


subject: UNII:71M78END5S


subject: UNII:71M78END5S


subject: UNII:71M78END5S

object_name: breast neoplasm


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:50162

subject_name: motexafin gadolinium hydrate

object_name: Untreated Childhood Brain Stem Glioma


subject: PUBCHEM.COMPOUND:9919910

subject_name: Xcytrin


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: seborrheic dermatitis


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:16977

subject_name: Alanine


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: amyotrophic lateral sclerosis


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C4547427

subject_name: (18F)T807 compound


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Muscle Invasive Bladder Urothelial Carcinoma


subject: UNII:AF75XOF6W3

object_name: Bladder transitional cell carcinoma stage IV


subject: UNII:AF75XOF6W3

object_name: Bladder transitional cell carcinoma stage III


subject: UNII:AF75XOF6W3

object_name: Bladder transitional cell carcinoma stage II


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: CHEBI:232799

subject_name: insulin lispro

object_name: sarcopenia


subject: CHEBI:232799

object_name: multiple system atrophy


subject: CHEBI:232799

object_name: orthostatic hypotension


subject: CHEBI:232799

object_name: Diabetes


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: myocarditis


subject: UNII:7D0YB67S97

object_name: viral myocarditis


subject: UNII:7D0YB67S97

object_name: Myocarditis, CTCAE 5.0


subject: UNII:7D0YB67S97

object_name: Myocarditis, CTCAE 3.0


subject: UMLS:C0771948

subject_name: Fosfomycin sodium

object_name: Pseudomonas infection


subject: PUBCHEM.COMPOUND:3417


subject: CHEBI:28915

subject_name: Fosfomycin


subject: UMLS:C0360032

subject_name: EMLA Cream

object_name: diabetes mellitus


subject: UMLS:C3827112

object_name: neoplasm


subject: UMLS:C0106006

object_name: type 2 diabetes mellitus


subject: UMLS:C0106006

object_name: Heart Failure, CTCAE


subject: CHEBI:149520

subject_name: Polihexanide

object_name: nail disorder


subject: CHEBI:149520

object_name: Ingrown nail


subject: CHEBI:149520

object_name: skin disorder


subject: UNII:922OP8YUPF

subject_name: Huang Qi

object_name: Alzheimer disease type 1


subject: UNII:922OP8YUPF

object_name: Alzheimer disease


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: fragile X syndrome


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Opioid Misuse


subject: CHEBI:7459

subject_name: Naloxone


subject: CHEBI:174615

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:174615

object_name: Embolism, Tumor


subject: CHEBI:174615

object_name: Neoplasm Metastasis


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: PR:000017503

subject_name: solute carrier family 53 member 1

object_name: Restless legs


subject: PR:000006336

subject_name: L-xylulose reductase


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Weight Change


subject: MESH:D000077203

object_name: hypertension


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: PUBCHEM.COMPOUND:184196

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:184196

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:184196

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:184196

object_name: primary peritoneal carcinoma


subject: PUBCHEM.COMPOUND:184196

object_name: Primary Peritoneal Cancer


subject: PUBCHEM.COMPOUND:184196

object_name: fallopian tube carcinoma


subject: PUBCHEM.COMPOUND:184196

object_name: fallopian tube cancer


subject: UMLS:C4048807


subject: UMLS:C4048807


subject: UMLS:C4048807


subject: UMLS:C4048807


subject: UMLS:C4048807


subject: UMLS:C4048807


subject: UMLS:C4048807


subject: CHEBI:9123

subject_name: Sertraline

object_name: mood (physical finding)


subject: CHEBI:9123

object_name: Premenstrual Dysphoric Disorder


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Maternity blues


subject: CHEBI:27791

subject_name: Diquafosol

object_name: Dry Eye, CTCAE


subject: CHEBI:27791

object_name: Dryness of eye


subject: UMLS:C5707962

subject_name: Buntanetap

object_name: Alzheimer disease type 1


subject: UMLS:C5707962

object_name: Alzheimer disease


subject: UMLS:C3495568

object_name: HIV-1 infection


subject: UNII:7BA3X03948

subject_name: BERUBICIN HYDROCHLORIDE

object_name: High grade glioma


subject: UNII:7BA3X03948

object_name: malignant glioma


subject: UMLS:C2713012

subject_name: Berubicin Hydrochloride


subject: UMLS:C2713012


subject: UNII:7CAZ46X8EL

subject_name: SEPOFARSEN

object_name: retinal degeneration


subject: UNII:7CAZ46X8EL

object_name: inherited retinal dystrophy


subject: PUBCHEM.COMPOUND:11281445

subject_name: NAVARIXIN

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:11281445

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:11281445

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:168310632

subject_name: Navarixin


subject: PUBCHEM.COMPOUND:168310632


subject: PUBCHEM.COMPOUND:168310632


subject: UMLS:C5543952


subject: UNII:TWQ8K8A81Y

subject_name: Larotaxel

object_name: breast neoplasm


subject: UMLS:C2603884


subject: MESH:C000600413


subject: MESH:C000600413


subject: MESH:C000600413


subject: UMLS:C0873019

subject_name: Berberine hydrochloride

object_name: type 2 diabetes mellitus


subject: CHEBI:52717

subject_name: Bortezomib

object_name: lymphoproliferative syndrome


subject: CHEMBL.COMPOUND:CHEMBL5095317

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:31859

subject_name: Modafinil

object_name: psychosis


subject: CHEBI:31859

object_name: Nonorganic psychosis


subject: CHEBI:31859

object_name: Psychosis, CTCAE


subject: CHEBI:31859

object_name: schizophreniform disorder


subject: CHEBI:31859

object_name: Psychotic disorder due to a general medical condition


subject: UMLS:C0675750

subject_name: SANORG 34006

object_name: pulmonary embolism


subject: UMLS:C0675750

object_name: Deep vein thrombosis of lower limb


subject: UMLS:C0675750

object_name: Deep venous thrombosis


subject: UNII:H84IXP29FN

subject_name: IDRAPARINUX SODIUM


subject: UNII:H84IXP29FN


subject: UNII:H84IXP29FN


subject: PUBCHEM.COMPOUND:44284701

subject_name: Idraparinux


subject: PUBCHEM.COMPOUND:44284701


subject: PUBCHEM.COMPOUND:44284701


subject: UMLS:C4508869

subject_name: idraparinux sodium


subject: UMLS:C4508869


subject: UMLS:C4508869


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: Reactive hypoglycemia


subject: CHEBI:40237

subject_name: Sitagliptin


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: psoriasis vulgaris


subject: CHEBI:9150

subject_name: Simvastatin

object_name: myopathy


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: primary central nervous system lymphoma


subject: UNII:R8DG7T2D3A

object_name: malignant glioma


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: PUBCHEM.COMPOUND:70693549

subject_name: SUGAMMADEX SODIUM

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:70693549

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:70693549

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:70693549

object_name: obesity


subject: PUBCHEM.COMPOUND:70693549

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: PUBCHEM.COMPOUND:74030550


subject: PUBCHEM.COMPOUND:74030550


subject: PUBCHEM.COMPOUND:74030550


subject: PUBCHEM.COMPOUND:74030550


subject: CHEBI:15365

subject_name: Aspirin

object_name: Acute migraine


subject: CHEBI:50202

subject_name: naringenin

object_name: Safety Issues


subject: CHEBI:17579

subject_name: Beta carotene


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: coronary microvascular disorder


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Recurrent WHO Grade 4 Glioma


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: Recurrent Childhood Glioblastoma


subject: UNII:2Y3T5IF01Z

object_name: Recurrent Glioblastoma


subject: UNII:2Y3T5IF01Z


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: CHEBI:27732

subject_name: Caffeine

object_name: bronchiolitis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Cough, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C5417968

subject_name: STING Agonist TAK-676

object_name: head and neck squamous cell carcinoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Loss of Chromosome 17p


subject: CHEBI:52717

object_name: chromosome 17p deletion


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168

object_name: plasma cell leukemia


subject: CHEBI:4466

object_name: Physical trauma


subject: CHEBI:4466

object_name: Injury


subject: CHEBI:4466

object_name: Trauma


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:131166

subject_name: Berzosertib

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:131166

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:131166

object_name: Unresectable Gastric Adenocarcinoma


subject: CHEBI:131166

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:131166

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:131166

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:131166

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:131166

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: PUBCHEM.COMPOUND:72995949

subject_name: Voclosporin

object_name: EXCESS LMW-DNA


subject: UMLS:C5706345

subject_name: Anti-PD-L1/Anti-OX40 Bispecific Antibody EMB-09

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:49086

object_name: traumatic encephalopathy


subject: CHEBI:49086

object_name: traumatic brain injury


subject: CHEBI:49086

object_name: Dependence


subject: CHEBI:49086

object_name: Harmful pattern of substance use


subject: CHEBI:49086

object_name: substance abuse


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:16436


subject: CHEBI:16436


subject: CHEBI:16436


subject: CHEBI:16436


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: UMLS:C5240001

subject_name: Vaccine product containing only Measles morbillivirus antigen (medicinal product)

object_name: diphtheria


subject: UMLS:C5240001

object_name: pertussis


subject: UMLS:C5240001

object_name: tetanus


subject: CHEBI:26580

subject_name: Rifamycin

object_name: Impacted third molar tooth


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Inflammatory Response


subject: CHEBI:8802

object_name: breast disorder


subject: CHEBI:74947

subject_name: Thalidomide

object_name: burning mouth syndrome


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Locally Advanced Paraganglioma


subject: UNII:MRL3739G66

object_name: Unresectable Paraganglioma


subject: UNII:MRL3739G66

object_name: Malignant Paraganglioma


subject: UNII:MRL3739G66

object_name: Metastatic Parathyroid Gland Carcinoma


subject: UNII:MRL3739G66

object_name: pituitary adenocarcinoma


subject: UNII:MRL3739G66

object_name: Stage IV Thyroid Gland Medullary Carcinoma AJCC v8


subject: UNII:MRL3739G66

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v8


subject: UNII:MRL3739G66

object_name: Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8


subject: UNII:MRL3739G66

object_name: Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8


subject: UNII:MRL3739G66

object_name: Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8


subject: UNII:MRL3739G66

object_name: Locally Advanced Adrenal Gland Pheochromocytoma


subject: UNII:MRL3739G66

object_name: Unresectable Adrenal Gland Pheochromocytoma


subject: UNII:MRL3739G66

object_name: malignant adrenal gland pheochromocytoma


subject: UMLS:C4026303

subject_name: Epanova

object_name: hypertriglyceridemia


subject: UMLS:C4026303

object_name: Hypertriglyceridemia, CTCAE


subject: UMLS:C3642376

object_name: ovarian cancer


subject: UMLS:C3642376

object_name: ovarian neoplasm


subject: UMLS:C3642376

object_name: ovarian carcinoma


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: Grade III Childhood Astrocytoma


subject: DRUGBANK:DB15803

object_name: Adult Anaplastic Astrocytoma


subject: DRUGBANK:DB15803

object_name: anaplastic astrocytoma


subject: CHEBI:36704

subject_name: Imiquimod

object_name: High grade glioma


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: pulmonary hypertension


subject: UNII:2XLN4Y044H

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: PUBCHEM.COMPOUND:22451303


subject: CHEBI:15372

object_name: kidney disorder


subject: CHEBI:15372

object_name: impaired renal function disease


subject: CHEBI:15372

object_name: Albuminuria


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: PUBCHEM.COMPOUND:129630809


subject: PUBCHEM.COMPOUND:129630809


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: CHEBI:59560


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:50634

object_name: thoracic aortic aneurysm


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:37845

subject_name: growth hormone

object_name: Werner syndrome


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: UMLS:C3256182

subject_name: Sedum roseum root extract

object_name: Depressed mood


subject: UMLS:C3256182

object_name: Cancer patients and suicide and depression


subject: UMLS:C3256182

object_name: Depressed - symptom


subject: UMLS:C3256182

object_name: Depression, CTCAE


subject: UMLS:C3256182

object_name: Stress


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Low back pain


subject: UMLS:C0013227

object_name: Chronic low back pain


subject: UMLS:C0013227

object_name: neuralgia


subject: UMLS:C0013227

object_name: Neuropathic pain


subject: UMLS:C0013227

object_name: Nociplastic Pain


subject: UMLS:C0013227

object_name: Acute low back pain


subject: UMLS:C0013227

object_name: chronic pain (diagnosis)


subject: UMLS:C0013227

object_name: Chronic pain


subject: UMLS:C0013227

object_name: sleep disorder


subject: UMLS:C0013227

object_name: fibromyalgia


subject: UMLS:C5203926

subject_name: EZH2 Inhibitor SHR2554

object_name: prostate carcinoma


subject: UMLS:C5203926

object_name: prostate cancer


subject: UMLS:C5203926

object_name: castration-resistant prostate carcinoma


subject: UNII:70FJN2AW22


subject: UMLS:C4287708

subject_name: Androgen Receptor Antagonist SHR3680


subject: MESH:C027128

subject_name: Antitumor B

object_name: Well adult


subject: UMLS:C1831899

subject_name: Alpharadin


subject: UMLS:C1831899


subject: CHEBI:145500

subject_name: thiencarbazone-methyl

object_name: Community-Acquired Infections


subject: CHEBI:35255

subject_name: Chloroform


subject: UNII:CR743OME9E

object_name: psoriasis


subject: UMLS:C4087001

object_name: Papulopustular Rosacea


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: endometrial cancer


subject: UNII:PVI5M0M1GW

object_name: uterine corpus cancer


subject: UNII:PVI5M0M1GW

object_name: endometrial carcinoma


subject: UNII:PVI5M0M1GW

object_name: cervical cancer


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Acquired trigger finger


subject: CHEBI:6888

object_name: trigger thumb


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: liver disorder


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination

object_name: pancreatic neoplasm


subject: UMLS:C0250480

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0250480

object_name: malignant pancreatic neoplasm


subject: UMLS:C0250480

object_name: pancreas disorder


subject: CHEBI:10983

object_name: Ketosis


subject: CHEBI:10983

object_name: Ketoacidosis


subject: UMLS:C5204823

object_name: non-small cell lung carcinoma


subject: UMLS:C5204823

object_name: small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108252

subject_name: APOLIZUMAB

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: recurrent adult acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: nodal marginal zone B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: splenic marginal zone lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: Marginal zone lymphoma stage IV


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: Marginal zone lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: Marginal zone lymphoma stage III


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: MALT lymphoma


subject: UMLS:C1120775

subject_name: Hu1D 10


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: GTOPDB:13543

subject_name: inotersen

object_name: hereditary amyloidosis


subject: UNII:0IEO0F56LV

subject_name: Inotersen


subject: CHEBI:6775

subject_name: Mesalazine

object_name: Irritable bowel syndrome with diarrhea


subject: UMLS:C2827069

subject_name: BCG Solution

object_name: Stage I Carcinoma of Bladder


subject: UMLS:C2827069

object_name: Bladder cancer recurrent


subject: UMLS:C2827069

object_name: bladder carcinoma in situ


subject: UMLS:C2827069

object_name: Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: bacterial infectious disease


subject: UMLS:C0041044


subject: UMLS:C5447421

subject_name: ERK1/2 Inhibitor ATG-017

object_name: Childhood Solid Neoplasm


subject: UMLS:C5447421

object_name: Adult Solid Neoplasm


subject: UMLS:C5447421

object_name: Solid Neoplasm


subject: UMLS:C5447421

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C0003233

subject_name: Antibiotics, Aminoglycoside

object_name: Fractured lower leg


subject: CHEBI:47779

subject_name: aminoglycoside


subject: MESH:D000097904

subject_name: First Generation Cephalosporins


subject: UNII:7K5O7P6QIU

subject_name: LONCASTUXIMAB

object_name: High grade B-cell lymphoma refractory


subject: UNII:7K5O7P6QIU

object_name: Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:7K5O7P6QIU

object_name: Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:7K5O7P6QIU

object_name: High grade B-cell lymphoma recurrent


subject: UNII:7K5O7P6QIU

object_name: Refractory Grade 3b Follicular Lymphoma


subject: UNII:7K5O7P6QIU

object_name: Refractory Transformed Chronic Lymphocytic Leukemia


subject: UNII:7K5O7P6QIU

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UNII:7K5O7P6QIU

object_name: Recurrent Transformed Chronic Lymphocytic Leukemia


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:LDJ89SS0YG

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UNII:LDJ89SS0YG

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG


subject: UNII:LDJ89SS0YG


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: CHEBI:95067

subject_name: Iniparib

object_name: primary peritoneal carcinoma


subject: CHEBI:95067

object_name: Primary Peritoneal Cancer


subject: PUBCHEM.COMPOUND:167713195

subject_name: leritrelvir

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:2735

object_name: Chronic Kidney Disease, CTCAE


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3273366

object_name: abdominal aortic aneurysm


subject: UMLS:C3273366

object_name: carotid atherosclerosis


subject: UMLS:C1121746

subject_name: BIRB 796

object_name: psoriasis


subject: PUBCHEM.COMPOUND:64987

object_name: Drug usage


subject: PUBCHEM.COMPOUND:64987

object_name: Drug use history


subject: PUBCHEM.COMPOUND:64987

object_name: Encounter due to drug use


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: CHEBI:63625


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)

object_name: Adherence To Medication Regime


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: PR:000015643


subject: PR:000015643


subject: CHEBI:173106

subject_name: ferroptocide


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:173106


subject: CHEBI:66964

subject_name: Dronabinol

object_name: irritable bowel syndrome


subject: UMLS:C5959205

subject_name: Anti-PSMA/STEAP1 Antibody-drug Conjugate ABBV-969

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: PUBCHEM.COMPOUND:25127414

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:25127414

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:25127414

object_name: malignant pancreatic neoplasm


subject: UNII:0ICW2LX8AS

subject_name: Bemcentinib


subject: UNII:0ICW2LX8AS


subject: UNII:0ICW2LX8AS


subject: CHEBI:48131

subject_name: Azelaic acid

object_name: Postinflammatory hyperpigmentation


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Crohn disease


subject: CHEBI:87681

object_name: inflammatory bowel disease


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: male breast carcinoma


subject: CHEBI:175901

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:175901

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:231347

subject_name: Triapine


subject: CHEBI:231347


subject: CHEBI:231347

object_name: Carcinoma breast stage IV


subject: CHEBI:231347


subject: CHEBI:231347

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:231347

object_name: Breast cancer recurrent


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Vitamin C deficiency anemia


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Acute Stroke


subject: CHEBI:68558

object_name: Acute Stroke Related to COVID-19


subject: UMLS:C3179434

subject_name: Brilique

object_name: Ischemic stroke


subject: UMLS:C3179434


subject: UMLS:C3179434


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:63637

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan

object_name: age-related macular degeneration


subject: CHEBI:23965

subject_name: estradiol

object_name: Encounter due to hormone replacement therapy


subject: CHEBI:23965

object_name: hypogonadism; ovarian


subject: UMLS:C5552948

subject_name: Clostridial Collagenase Ointment

object_name: diabetic foot


subject: UMLS:C5552948

object_name: Foot Ulcer


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: BRCA1 gene mutation


subject: UNII:4EQZ6YO2HI

object_name: breast disorder


subject: UNII:4EQZ6YO2HI

object_name: breast neoplasm


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:137080

object_name: polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: ERBB2 mutation-related tumors


subject: GTOPDB:13716

object_name: ERBB2 gene duplication


subject: GTOPDB:13716

object_name: non-small cell lung carcinoma


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: UNII:CJN36EQM0H


subject: UNII:T4RS462G19

subject_name: Almonertinib


subject: UNII:T4RS462G19


subject: UMLS:C5700426

subject_name: furmonertinib


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: CHEMBL.COMPOUND:CHEMBL5095039

subject_name: GALLIUM GA 68 GOZETOTIDE

object_name: liver carcinoma


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA


subject: CHEBI:22586

subject_name: antioxidant

object_name: Tinnitus


subject: CHEBI:22586

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:22586

object_name: Tinnitus, CTCAE 3.0


subject: UMLS:C0003402

subject_name: Antioxidants


subject: UMLS:C0003402


subject: UMLS:C0003402


subject: PUBCHEM.COMPOUND:2269

object_name: infectious disease


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: osteoarthritis, knee


subject: CHEBI:66910

subject_name: Axitinib

object_name: Recurrent Clear Cell Renal Cell Carcinoma


subject: CHEBI:66910

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:66910

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: CHEBI:40279

subject_name: Allopurinol

object_name: congestive heart failure


subject: UMLS:C1328728

object_name: cervical cancer


subject: UMLS:C1328728

object_name: cervical carcinoma


subject: CHEBI:95165

object_name: refractory malignant neoplasm


subject: CHEBI:95165

object_name: Recurrent Carcinoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UNII:DPT0O3T46P


subject: UNII:80LIU5P95D

object_name: cystic fibrosis


subject: UMLS:C2979932

object_name: HIV infection


subject: MESH:C046637

subject_name: neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination


subject: UMLS:C4309815

subject_name: BAX 855

object_name: hemophilia A


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: ulcerative colitis


subject: CHEBI:39548

object_name: inflammatory bowel disease 1


subject: CHEBI:39548

object_name: colorectal carcinoma


subject: CHEBI:63607

subject_name: Linezolid

object_name: ventilator-associated pneumonia


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Shivering


subject: PUBCHEM.COMPOUND:155885731

subject_name: Maribavir


subject: CHEMBL.COMPOUND:CHEMBL2109465

object_name: interstitial lung disease 1


subject: CHEMBL.COMPOUND:CHEMBL2109465

object_name: interstitial lung disease 2


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: cellulitis


subject: RXCUI:8375

object_name: cellulitis on exam (physical finding)


subject: RXCUI:8375

object_name: erysipelas


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8774

subject_name: Ramipril

object_name: acute coronary syndrome


subject: CHEBI:8774

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:8774

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:9434

subject_name: Telmisartan

object_name: myocardial infarction


subject: CHEBI:9434


subject: CHEBI:9434


subject: UMLS:C0768182

subject_name: Bexxar

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: endometrioid adenocarcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Locally Advanced Breast Carcinoma


subject: CHEBI:31355

object_name: Unresectable Breast Carcinoma


subject: CHEBI:62880

subject_name: Veliparib

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: periodontitis, aggressive 1


subject: CHEBI:63611

object_name: acute pericementitis


subject: CHEBI:63611

object_name: generalized aggressive periodontitis


subject: CHEBI:27470

subject_name: Folic acid

object_name: aortic valve disease 2


subject: CHEBI:27470

object_name: aortic stenosis


subject: CHEBI:27470

object_name: aortic valve disease 3


subject: CHEBI:27470

object_name: Stenosis of aorta


subject: CHEBI:27470

object_name: aortic valve calcification


subject: PUBCHEM.COMPOUND:13889162

subject_name: Isomaltoside

object_name: anemia


subject: PUBCHEM.COMPOUND:13889162

object_name: Anemia, CTCAE


subject: UMLS:C4329513

object_name: ovarian cancer


subject: UMLS:C4329513

object_name: ovarian neoplasm


subject: UMLS:C4329513

object_name: ovarian carcinoma


subject: UNII:XX2MN88N5D

subject_name: Efalizumab

object_name: diabetic macular edema


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Stress Fracture


subject: UMLS:C4727173

subject_name: Aspacytarabine

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: thyroid Hurthle cell carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: thyroid gland follicular carcinoma


subject: CHEBI:81567

subject_name: Thyrotropin


subject: CHEBI:81567

object_name: thyroid gland papillary carcinoma


subject: CHEBI:81567


subject: UMLS:C0876183

subject_name: Thyrogen


subject: UMLS:C0876183


subject: UMLS:C0876183


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Amnesia, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine

object_name: amnesia


subject: UNII:7N8K34P2XH


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:231683

subject_name: Anakinra

object_name: acute myocardial infarction


subject: CHEBI:231683

object_name: Acute Myocardial Infarction by ECG Finding


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: UMLS:C1138321

subject_name: glutoxim


subject: UMLS:C1138321


subject: UMLS:C1138321


subject: PUBCHEM.COMPOUND:23724990

subject_name: Phytate Sodium

object_name: bipolar disorder


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Dysmenorrhea


subject: MESH:C000730637

object_name: Parkinson disease


subject: CHEBI:74705

subject_name: Met-Leu

object_name: motor neuron disorder


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:32682

subject_name: L-argininium

object_name: oligohydramnios


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:33284

subject_name: nutrient

object_name: congenital alveolar dysplasia


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: Multiple sclerosis relapse


subject: UMLS:C0665297

subject_name: natalizumab


subject: UMLS:C1521807

object_name: malignant soft tissue neoplasm


subject: UMLS:C1521807

object_name: sarcoma


subject: UMLS:C1521807

object_name: prostate carcinoma


subject: UMLS:C1521807

object_name: prostate cancer


subject: UMLS:C1521807

object_name: Childhood Breast Carcinoma


subject: UMLS:C1521807

object_name: breast carcinoma


subject: UMLS:C1521807

object_name: breast cancer


subject: UMLS:C1521807

object_name: Neck Carcinoma


subject: UMLS:C1521807

object_name: head and neck neoplasm


subject: UMLS:C1521807

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: endometriosis


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:101854

subject_name: talarozole

object_name: psoriasis


subject: CHEBI:102167

subject_name: Talarozole


subject: UMLS:C4760178

subject_name: Neuromuscular blockade drugs

object_name: colorectal cancer


subject: UMLS:C4760178

object_name: colorectal carcinoma


subject: UMLS:C4760178

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:64356

subject_name: Pregabalin

object_name: myofascial pain syndrome


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: mood disorder


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:37924

subject_name: Atazanavir

object_name: Abnormality of mitochondrial metabolism


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Pharyngalgia


subject: CHEBI:6456

object_name: Sore Throat, CTCAE


subject: CHEBI:233408

subject_name: Olesoxime

object_name: spinal muscular atrophy, type II


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: vulva cancer


subject: UNII:2S9ZZM9Q9V

object_name: vulva carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: vaginal cancer


subject: UNII:2S9ZZM9Q9V

object_name: vaginal neoplasm


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: endometrial clear cell adenocarcinoma


subject: UNII:P0GVQ9A4S5

object_name: clear cell adenocarcinoma


subject: UNII:P0GVQ9A4S5

object_name: cervical polyp


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C3489972

object_name: Thromboembolism


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: ovarian cancer


subject: UMLS:C4287690

object_name: ovarian neoplasm


subject: UMLS:C4287690

object_name: ovarian carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:41879

object_name: Metastatic non-small cell lung cancer


subject: GTOPDB:8371

subject_name: abicipar pegol

object_name: Macular Edema


subject: CHEMBL.COMPOUND:CHEMBL4297684

subject_name: ABICIPAR PEGOL


subject: UMLS:C4519646


subject: UMLS:C4291350

subject_name: Scutellaria barbata whole extract

object_name: Childhood Breast Carcinoma


subject: UMLS:C4291350

object_name: breast carcinoma


subject: UMLS:C4291350

object_name: breast cancer


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:51450

subject_name: Bosentan


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin


subject: CHEBI:180911

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:180911

object_name: Carcinoma breast stage IV


subject: CHEBI:180911

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:180911

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:180911

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:180911

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:180911

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:180911

object_name: Breast cancer recurrent


subject: CHEBI:45906

subject_name: Suramin


subject: CHEBI:45906


subject: CHEBI:45906


subject: CHEBI:45906


subject: CHEBI:45906


subject: CHEBI:45906


subject: CHEBI:45906


subject: CHEBI:45906


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: adrenocortical insufficiency


subject: PUBCHEM.COMPOUND:21628493

object_name: Adrenal Insufficiency, CTCAE


subject: PUBCHEM.COMPOUND:21628493

object_name: Female hypogonadism


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:4903


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Adhesive Capsulitis


subject: CHEBI:60802

object_name: frozen shoulder


subject: CHEBI:60802

object_name: bursitis


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: malignant pleural mesothelioma


subject: UMLS:C1328149

object_name: neoplasm


subject: CHEBI:63453

object_name: non-small cell lung carcinoma


subject: CHEBI:63453

object_name: squamous cell carcinoma


subject: CHEBI:63453

object_name: esophageal adenocarcinoma


subject: CHEBI:63453

object_name: lung adenocarcinoma


subject: CHEBI:63453

object_name: cervical adenocarcinoma


subject: CHEBI:63453

object_name: adenocarcinoma


subject: CHEBI:63453

object_name: bile duct adenocarcinoma


subject: CHEBI:63453

object_name: gastric adenocarcinoma


subject: UMLS:C3502775


subject: UMLS:C3502775


subject: UMLS:C3502775


subject: UMLS:C3502775


subject: UMLS:C3502775


subject: UMLS:C3502775


subject: UMLS:C3502775


subject: UMLS:C3502775


subject: CHEBI:231342

subject_name: ceralasertib


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: CHEBI:77562

subject_name: rac-crizotinib


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib


subject: UNII:CWG62Q1VTB


subject: UNII:CWG62Q1VTB


subject: UNII:CWG62Q1VTB


subject: UNII:CWG62Q1VTB


subject: UNII:CWG62Q1VTB


subject: UNII:CWG62Q1VTB


subject: UNII:0BSC3P4H5X

subject_name: Vistusertib


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: PUBCHEM.COMPOUND:42602260


subject: PUBCHEM.COMPOUND:42602260


subject: PUBCHEM.COMPOUND:42602260


subject: PUBCHEM.COMPOUND:42602260


subject: PUBCHEM.COMPOUND:42602260


subject: PUBCHEM.COMPOUND:42602260


subject: PUBCHEM.COMPOUND:42602260


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: NK-lymphoblastic leukemia/lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: PUBCHEM.COMPOUND:343523

object_name: Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:343523

object_name: Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:343523

object_name: sarcoma


subject: PUBCHEM.COMPOUND:343523

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:343523

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:343523

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:343523

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:343523

object_name: Recurrent Soft Tissue Sarcoma


subject: PUBCHEM.COMPOUND:343523

object_name: Resectable Soft Tissue Sarcoma


subject: CHEBI:49166

subject_name: fluorodopa F 18


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:49166


subject: CHEBI:32816

subject_name: Pyruvic acid

object_name: Moderate asthma


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:9824461

object_name: Diabetes


subject: PUBCHEM.COMPOUND:9824461

object_name: diabetes mellitus


subject: CHEBI:67271

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:67271

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:135967

subject_name: Casopitant

object_name: insomnia


subject: CHEBI:135967

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:135967

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:135967

object_name: sleep disorder, initiating and maintaining sleep


subject: UMLS:C1831798


subject: UMLS:C1831798


subject: UMLS:C1831798


subject: UMLS:C1831798


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: Disorder related to renal transplantation


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:139072

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:139072

object_name: amyotrophic lateral sclerosis


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:87681

subject_name: Ranolazine

object_name: acute coronary syndrome


subject: UNII:B321AL142J

subject_name: molgramostim

object_name: cystic fibrosis


subject: UNII:B321AL142J

object_name: bronchiectasis


subject: UNII:B321AL142J

object_name: acute respiratory distress syndrome


subject: UNII:B321AL142J

object_name: adult acute respiratory distress syndrome


subject: UNII:B321AL142J

object_name: pulmonary alveolar proteinosis


subject: UMLS:C0218633


subject: UMLS:C0218633


subject: UMLS:C0218633


subject: UMLS:C0218633


subject: UMLS:C0218633


subject: UMLS:C5238974

object_name: primary peritoneal carcinoma


subject: UMLS:C5238974

object_name: Primary Peritoneal Cancer


subject: CHEBI:9434

subject_name: Telmisartan

object_name: HIV infection


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: dentin sensitivity


subject: CHEBI:39585

subject_name: Carbidopa


subject: UMLS:C0972569

subject_name: Electrophoresis Gel


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine

object_name: Heartburn


subject: CHEBI:8776

subject_name: ranitidine


subject: UNII:621XR2W6OP

subject_name: Methylprednisone

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:5126752


subject: CHEBI:135573

subject_name: Meprednisone


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Fallopian Tube Serous Neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: ovarian seromucinous tumor


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355

object_name: fallopian tube carcinosarcoma


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: ovarian carcinosarcoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:62880

subject_name: Veliparib

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:62880

object_name: peritoneal carcinoma


subject: CHEBI:62880

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:62880

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:62880

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:62880

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:62880

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:62880

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:62880

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: CHEBI:62880

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:62880

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:62880

object_name: Fallopian Tube Serous Neoplasm


subject: CHEBI:62880

object_name: fallopian tube carcinosarcoma


subject: CHEBI:62880

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:62880

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: fallopian tube transitional cell carcinoma


subject: CHEBI:62880

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7